NewJour Home |
NewJour: N |
Search
[Prev] [Next]
National Cancer Institute. Journal.
-- Begin filtered message --
From newjour-owner@ccat.sas.upenn.edu Fri Sep 27 21:35:47 1996
Received: (CCAT.SAS.UPENN.EDU [130.91.74.102]) by weber.ucsd.edu (8.7.5/8.7.3) with ESMTP id VAA05143 for <ss3@weber.ucsd.edu>; Fri, 27 Sep 1996 21:35:45 -0700 (PDT)
Received: (from root@localhost) by ccat.sas.upenn.edu (8.7.6/8.7.3) id VAA44769 for newjour-outgoing; Fri, 27 Sep 1996 21:17:46 GMT
Date: Fri, 27 Sep 1996 21:17:46 GMT
From: owner-newjour@ccat.sas.upenn.edu
Message-Id: <199609272117.VAA44769@ccat.sas.upenn.edu>
Subject: National Cancer Institute. Journal.
Sender: owner-newjour@ccat.sas.upenn.edu
Precedence: bulk
Date: Mon, 09 Sep 1996 20:52:03 -0400
From: "Robert W. Hammond" <rhammond@mediquest.com>
Organization: Medical Services Online LLC
Subject: Re: Journals for New Jour
National Cancer Institute. Journal.
http://medserv.com/jnci/toc/v88n17.htm
(Link inactive 24 June 2004)
http://jncicancerspectrum.oupjournals.org/
(Link active 24 June 2004)
The Journal of the National Cancer Institute is part of the Oncology
Online. Membership is presently open to physicians and Ph.D. researchers
based in the United States. Similar services are under development for
international member candidates. U.S. Physicians who have a DEA number
may register online now. You will not be able to access this title
without proper registration and password clearance.
Available issues in full text go back to Volume 88, no. 1, January 17,
1996.
The National Cancer Institute does not guarantee that this electronic
edition of the Journal of the National Cancer Institute (JNCI) is free of
errors or omissions. Readers are advised to consult the print edition of
the JNCI for the authoritative text.
The Journal of the National Cancer Institute is a forum for news,
information, and ideas related to cancer research, treatment, prevention,
and control. Accordingly, all articles and items published in the Journal
are signed and, unless otherwise stated, reflect the individual views of
the authors and not official points of view held by the National Cancer
Institute, any other component of the U.S. government, or the
organizations with which the authors are affiliated. The mention of trade
names, commercial products, or organizations does not imply endorsement by
the National Cancer Institute or any other component of the U.S.
government. Neither the National Cancer Institute nor any other component
of the U.S. government assumes any responsibility for the completeness of
the articles or other items or the accuracy of the conclusions reached
therein.
The Journal of the National Cancer Institute (ISSN 0027-8874) is published
semimonthly by the National Cancer Institute, National Institutes of
Health, Public Health Service, U.S. Department of Health and Human
Services, at 9030 Old Georgetown Rd., Bethesda, MD 20814.
Second class postage paid at Bethesda, MD, and additional mailing offices.
All inquiries about subscriptions or depository library distribution
should be directed to the National Cancer Institute (telephone:
1-800-624-7890 in the United States or 301-496-7600 outside the United
States; fax: 301-231-6941).
The Journal of the National Cancer Institute has been deemed by the
Secretary of Health and Human Services to be necessary in the transaction
of the public business required by law of this department. Use of funds
for printing this periodical has been approved by the Director of the
Office of Management and Budget. All material published in the Journal is
in the public domain; permission to reproduce any portion of its contents
is, therefore, not necessary. Questions about manuscript submission or
other editorial matters may be addressed to the Journal Office, Rm. 209,
9030 Old Georgetown Rd., Bethesda, MD 20814 (telephone: 301-496-6975; fax:
301-402-0212). Questions about placing public service announcements of
employment openings, fellowship opportunities, and upcoming meetings may
be addressed to the Announcements Editor in Rm. 217 at the same address.
(Note: Announcements for the News section should be sent to J. Paul Van
Nevel, Bldg. 31, Rm. 10A29, Bethesda, MD 20892.)
-- End of filtered message --
NewJour Home |
NewJour: N |
Search
[Prev] [Next]